Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Neumann

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Geburtshilfe Und Frauenheilkunde|February 1, 1987
[HELLP syndrome: a life-threatening form of pre-eclampsia]R P de Dycker, R L Neumann
Geburtshilfe Und Frauenheilkunde|April 1, 1989
[Spindle cell sarcoma of the female breast]R P de Dycker, T Schumacher, R L Neumann
Geburtshilfe Und Frauenheilkunde|May 1, 1991
[Adjuvant chemotherapy in dysgerminoma]A Fechtig, R P de Dycker, T Schumacher, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1992
[Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol]A Fechtig, R P de Dycker, T Schumacher, et al.
Radiology|March 1, 1981
Scintigraphic diagnosis of cirrhosis: a receiver operator characteristic analysis of the common interpretative criteriaT R Simon, R L Neumann, F Gorelick, et al.
Deutsche Medizinische Wochenschrift (1946)|August 5, 1988
[Arterial regional chemotherapy of advanced breast cancer]R P de Dycker, J Timmermann, R L Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: an update based on 10 years' follow-up. German Breast Cancer Study GroupW Sauerbrei, G Bastert, H Bojar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Geburtshilfe Und Frauenheilkunde|February 1, 1987
[HELLP syndrome: a life-threatening form of pre-eclampsia]R P de Dycker, R L Neumann
Geburtshilfe Und Frauenheilkunde|April 1, 1989
[Spindle cell sarcoma of the female breast]R P de Dycker, T Schumacher, R L Neumann
Geburtshilfe Und Frauenheilkunde|May 1, 1991
[Adjuvant chemotherapy in dysgerminoma]A Fechtig, R P de Dycker, T Schumacher, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1992
[Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol]A Fechtig, R P de Dycker, T Schumacher, et al.
Radiology|March 1, 1981
Scintigraphic diagnosis of cirrhosis: a receiver operator characteristic analysis of the common interpretative criteriaT R Simon, R L Neumann, F Gorelick, et al.
Deutsche Medizinische Wochenschrift (1946)|August 5, 1988
[Arterial regional chemotherapy of advanced breast cancer]R P de Dycker, J Timmermann, R L Neumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: an update based on 10 years' follow-up. German Breast Cancer Study GroupW Sauerbrei, G Bastert, H Bojar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study GroupM Schumacher, G Bastert, H Bojar, et al.
Pageof 1